Esperion Therapeutics Inc.
- Address
- 3891 Ranchero Drive Suite 150
Sponsor Overview
Specializations
Familial Hypercholesterolemia
Esperion Therapeutics Inc. focuses on clinical research in heterozygous familial hypercholesterolemia, with an emphasis on inherited lipid disorders that require targeted management of elevated LDL cholesterol.
- Heterozygous familial hypercholesterolemia
- Inherited dyslipidemia
- Cholesterol-lowering therapy
The sponsor’s research activity includes evaluation in pediatric patients and reflects interest in age-specific treatment considerations for children and adolescents living with this condition.
Paediatric Lipid Disorders
Clinical work supported by Esperion Therapeutics extends to children and adolescents with hypercholesterolemia, addressing therapeutic needs in younger populations affected by persistent lipid elevation.
- Paediatric patients
- Lipid metabolism
- Age-appropriate cardiovascular risk reduction
Research in this area centers on treatment use in patients aged 6 to 17 years, highlighting interest in therapeutic options suitable for early-life management of inherited cholesterol disorders.
Cardiometabolic Therapeutics
The sponsor’s trial portfolio is aligned with cardiometabolic medicine, particularly therapies designed to address abnormal cholesterol handling and the long-term risk burden associated with atherosclerotic cardiovascular disease.
- Atherosclerotic cardiovascular disease risk
- Non-statin lipid management
- Cholesterol biosynthesis and clearance
This area of interest connects lipid-focused treatment development with clinical care for patients whose genetic condition places them at increased cardiovascular risk.
Pharmacokinetic Evaluation
Esperion Therapeutics also shows interest in pharmacokinetics within its clinical studies, supporting understanding of how lipid-lowering therapy is handled in the body in younger patients with HeFH.
- Drug absorption
- Drug exposure
- Paediatric pharmacology
These research activities are relevant to the development of therapies intended for inherited cholesterol disorders across different age groups.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of Bempedoic Acid in Pediatric Patients with Heterozygous Familial Hypercholesterolemia |  Denmark Germany Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 11 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
11 centres- Address
- De Boelelaan 1117, 1081 HV Amsterdam
- Address
- Janusz-Korczak-Allee 12, 30173 Hanover
- Address
- Dr. Molewaterplein 40, 3015 GD Rotterdam
- Address
- Theodor-Stern-Kai 7, 60590 Frankfurt
- Address
- Carretera De La Ronda Circunvalacion S/n, 11407 Jerez de la Frontera
- Address
- Passeig De Sant Joan De Deu 2, 08950 Esplugues de Llobregat
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Esperion Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.